Taeyoon Kyung

Title: Taeyoon Kyung: Innovator in Photosensitivity Research

Introduction

Taeyoon Kyung is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of photosensitivity through his innovative research and patents. His work is particularly focused on enhancing the properties of CRY2 variants.

Latest Patents

Taeyoon Kyung holds a patent for a CRY2 variant having increased photosensitivity. This patent, which is described as "CRY2 variant having increased photosensitivity and use thereof," involves a CRY2 variant where E279 and/or E281, which have a negative charge in a NSEGE sequence of SEQ ID NO: 1, is substituted with any one selected from the neutral amino acid group of alanine (A), isoleucine (I), leucine (L), valine (V), phenylalanine (F), methionine (M), and tryptophan (W). Additionally, S278 or G280 of the NSEGE sequence can be substituted with bulky amino acids such as tryptophan (W) and phenylalanine (F). This innovation has the potential to advance applications in various scientific fields.

Career Highlights

Taeyoon Kyung is affiliated with the Institute for Basic Science, where he conducts his research. His work has garnered attention for its potential applications in biotechnology and related areas. With a focus on enhancing photosensitivity, he continues to push the boundaries of scientific understanding.

Collaborations

Taeyoon has collaborated with notable colleagues, including Wondo Heo and Sungsoo Kim. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Taeyoon Kyung is a dedicated inventor whose work in photosensitivity research is paving the way for future innovations. His patent on the CRY2 variant exemplifies his commitment to advancing scientific knowledge and technology.